PharmaLex Group has appointed new executive vice president, business development and marketing in the form of Adrian Pencak.
Pencak joins the German consultancy group following over 25 years’ global business development, marketing and operations experience, spanning the life sciences and healthcare sectors.
He said: “I am very excited to have joined the PharmaLex management team as we are a company with ambitious growth targets as well as extremely high standards of services.
“I’m looking forward to playing a key role in our continued growth and success, with a special focus on the US.”
He joins the group from ICON, where he was vice president, global business development early phase services.
Dr Thomas Dobmeyer, chief executive officer at PharmaLex, said: “Adrian’s appointment demonstrates our commitment to developing our global infrastructure and sales.
“Alongside his strong business development experience, Adrian’s background in the IT space will also support our artificial intelligence and innovative led services.”